Mallinckrodt Plc
(NYSE : MNK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
PTLAPortola Pharmaceuticals, Inc. 0.03%17.836.5%$157.37m
MYOKMyoKardia, Inc. -3.97%104.251.8%$129.58m
HZNPHorizon Therapeutics Plc -4.89%46.916.5%$129.20m
BHCBausch Health Cos., Inc. -0.44%18.070.0%$117.12m
VRXValeant Pharmaceuticals International, Inc. -0.50%18.0614.1%$106.27m
CTLTCatalent, Inc. -3.82%73.572.3%$94.04m
UTHRUnited Therapeutics Corp. -3.40%114.4214.3%$75.19m
AXSMAxsome Therapeutics, Inc. -1.74%75.341.9%$73.57m
AMRNAmarin Corp. Plc -4.20%6.731.6%$63.99m
ICPTIntercept Pharmaceuticals, Inc. -3.68%73.6616.8%$57.21m
GWPHGW Pharmaceuticals Plc -4.85%124.806.2%$55.36m
JAZZJazz Pharmaceuticals Plc 1.00%110.412.4%$54.48m
PRGOPerrigo Co. Plc -0.16%54.786.8%$47.98m
ICLRICON plc -2.12%164.154.3%$45.84m
ARGXargenx SE -1.15%209.690.0%$38.60m

Company Profile

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.